In Brief: GSK consumer health up 4%, expansion costs hit P&G earnings, MJN faces headwinds, McKesson to take over Celesio
This article was originally published in The Tan Sheet
Executive Summary
GSK consumer health climbs 4%; expansion costs hit P&G earnings; Mead Johnson faces headwinds despite high sales; Nu Skin has ‘tremendous’ Q3; McKesson to takeover Celesio; more In Brief.